—VLO
— • —
$239.58
P/E
31.20
PEG
—
FCF Yield
—
Rev Growth YoY
-554.0% YoY
Gross Margin
443.0%
Health Score
5/10
D/E Ratio
0.45
Confidence
LOW
Business Snapshot
The ticker symbol and company name were not provided in this data payload, which limits contextual identification. Based on available data points — a current price of $239.58, a Price/Sales ratio of 0.59x, and a P/E of 31.2x — this appears to be an established operating business. Without market capitalisation data, cap-tier classification cannot be confirmed, though the low Price/Sales ratio of 0.59x is more consistent with a mid- or large-cap company in a capital-intensive or revenue-heavy industry.
Financial Health
**Score: 5/10** The balance sheet shows a conservative debt profile with a Debt/Equity ratio of 0.45x, suggesting limited leverage risk. The reported gross margin of 443.0% and net margin of 191.0% are extraordinarily high figures that likely reflect accounting adjustments, asset revaluations, or non-cash items rather than organic operational profitability — they warrant significant scrutiny and should not be taken at face value...
Risk Assessment
- **DATA INTEGRITY: Gross margin of 443% and net margin of 191% are mathematically implausible for most business models and suggest significant accounting distortions that obscure true profitability.** - **GROWTH: Revenue growth of -554.0% YoY and earnings growth of -977.0% represent extreme deterioration, regardless of whether driven by accounting or operational factors.** - **TECHNICALS: A confirmed death cross (50-day MA below 200-day MA) alongside a bearish MACD signal indicates deteriorating medium-to-long-term price momentum.** - **TRANSPARENCY: Free cash flow, TTM Revenue, TTM Net Income, market capitalisation, and DCF fair value are all unavailable, making comprehensive fundamental analysis impossible.** - **VALUATION ANCHOR: With no DCF estimate and anomalous margin figures, the P/E of 31.2x — above the sector average of 25x — cannot be validated against realistic earnings power.** ---...